Cover Image
市場調查報告書

第一型糖尿病(青少年糖尿病):全球臨床實驗檢討

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 146720
出版日期 內容資訊 英文 198 Pages
訂單完成後即時交付
價格
Back to Top
第一型糖尿病(青少年糖尿病):全球臨床實驗檢討 Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2014
出版日期: 2014年05月30日 內容資訊: 英文 198 Pages
簡介

本報告提供全球主要地區的第一型糖尿病(青少年糖尿病)治療藥臨床實驗數和受驗人數,各階段趨勢,再加上主要企業和機關,臨床實驗簡介等。

簡介

  • 第一型糖尿病(青少年糖尿病)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區前五名國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

參與第一型糖尿病(青少年糖尿病)臨床實驗的主要企業

有潛力的藥劑

最新臨床實驗新聞 第一型糖尿病(青少年糖尿病)

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novo A/S
    • Sanofi
    • Eli Lilly and Company
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • MannKind Corporation
    • Steno Diabetes Center A/S
    • Biodel Inc.
    • Medtronic, Inc.
    • GlaxoSmithKline plc
  • 代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • The National Institute of Allergy and Infectious Diseases
    • The Medical University of Graz
    • Baylor College of Medicine
    • Yale University
    • University of Virginia
    • University of Colorado
    • Rabin Medical Center
    • Massachusetts General Hospital
    • University of Minnesota

5個代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2184CTIDB

GlobalData's clinical trial report, "Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2014" provides data on the Type 1 Diabetes (Juvenile Diabetes) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type 1 Diabetes (Juvenile Diabetes). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Type 1 Diabetes (Juvenile Diabetes). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
  • Type 1 Diabetes (Juvenile Diabetes)
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Type 1 Diabetes (Juvenile Diabetes)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Type 1 Diabetes (Juvenile Diabetes)
    • Apr 14, 2014: LX4211 Achieves Positive Results In Type 1 Diabetes Clinical Trial
    • Apr 09, 2014: Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone Lispro
    • Mar 31, 2014: Halozyme Announces that Consistent 1 Trial Of Hylenex Recombinant Met Primary Endpoint
    • Mar 27, 2014: Oramed Pharmaceuticals Announces First Patient Enrolled in a US Phase 2a Trial for ORMD-0801 in Treatment of Type 1 Diabetes
    • Mar 20, 2014: Adocia confirms positive clinical results for its BioChaperone Combo, a combination of long-acting insulin glargine and fast-acting insulin lispro
    • Mar 10, 2014: Fibrotech announces positive Phase Ia results for anti-fibrotic FT011
    • Mar 05, 2014: Kamada Initiates Phase 2/3 Clinical Trial of Glassia to Treat Newly Diagnosed Pediatric Patients with Type 1 Diabetes
    • Mar 04, 2014: Novo Nordisk Successfully Completes Phase I Trial of its Proprietary Oral Insulin using Merrion Pharmaceuticals' GIPET Technology.
    • Feb 27, 2014: Adocia Announces Preliminary Positive Clinical Results for its Combination of Long-Acting Insulin Glargine and Fast-acting Insulin Analog Lispro, BioChaperone Combo
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novo A/S
      • Clinical Trial Overview of Novo A/S
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • MannKind Corporation
      • Clinical Trial Overview of MannKind Corporation
      • Steno Diabetes Center A/S
      • Clinical Trial Overview of Steno Diabetes Center A/S
      • Biodel Inc.
      • Clinical Trial Overview of Biodel Inc.
      • Medtronic, Inc.
      • Clinical Trial Overview of Medtronic, Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • The Medical University of Graz
      • Clinical Trial Overview of The Medical University of Graz
      • Baylor College of Medicine
      • Clinical Trial Overview of Baylor College of Medicine
      • Yale University
      • Clinical Trial Overview of Yale University
      • University of Virginia
      • Clinical Trial Overview of University of Virginia
      • University of Colorado
      • Clinical Trial Overview of University of Colorado
      • Rabin Medical Center
      • Clinical Trial Overview of Rabin Medical Center
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • University of Minnesota
      • Clinical Trial Overview of University of Minnesota
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind Corporation, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Steno Diabetes Center A/S, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Biodel Inc., 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014*

List of Figures

  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Type 1 Diabetes (Juvenile Diabetes) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Type 1 Diabetes (Juvenile Diabetes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top